Regulation

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Equivalence test case</h1><h2 class="title-bottom webtitle">Lessons from FDA approval of generic version of sanofi-aventis&apos; Lovenox</h2><div class="byline">BC Staff</div><div class="date"></div></div></div></div>

Equivalence test caseBy Susan Schaeffer Managing Editor......

Cardiovascular

Dermatology

Gastrointestinal

Infectious

Equivalence test case

The criteria FDA used to approve a generic enoxaparin from Momenta and Sandoz suggest that very high levels of scientific and technical acumen will be needed to win approval for copies of complex molecules.

Lessons from FDA approval of generic version of sanofi-aventis' Lovenox

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

Bio€quity Europe

BioCentury Grand Rounds 2024

BioCentury Grand Rounds

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Advertising - Sponsorship Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home